Good MorningEquity markets shrugged off the risk of a widening Middle Eastern conflict in favor of the interest rate and earnings outlook. With interest rates falling and expected to continue falling in 2025, S&P 500 earnings will continue to grow and build value for investors. In this scenario, the market can continue to rise indefinitely, and new highs will likely occur as the quarters progress. The technical target is now 6,000 and may be reached by year's end.
This week's risk is the CPI report on Thursday. Analysts forecast headline inflation to cool compared to last month and last year, keeping the FOMC on pace to cut rates again this year. The risk is two-fold: cooler-than-expected data could raise fears of a recession, while hotter-than-expected data will keep the FOMC from cutting as aggressively as indicated. The takeaway for investors is that S&P 500 volatility will remain high for the foreseeable future. Featured: Bigger Than Nvidia? (InvestorPlace) 
|
Markets | | |
Momentum trading involves buying rising stocks with the idea that they will continue rising. While reminiscent of the greater fools theory, momentum trading is more than buying high and selling high. Good momentum trades combine factors that help ensure the market is bullish and capable of continu... Read the Full Story |
|
From Our PartnersThere are very few people in this world who are considered “the best” in their field.
There are guys like Michael Jordan who is considered the best basketball player of all time…
Or Warren Buffet who is considered the best Investor of all time…
But we’ve just met a man who might be the best stock picker of all time…
Right now, as we speak, he is currently ranked the #1 stock picker in North America. | | | | If you’d like to sit down with us, follow this link here. |
|
Markets | | |
Every once in a while, a few stocks come under attack from short-selling firms or, essentially, by anyone that doesn’t align with that stock’s business or interests. It is tricky for retail investors to figure out whether short reports and attacks have any traction since they can often... Read the Full Story |
|
Stocks | | | U.S. stocks set records Wednesday after the latest wild swerves for Chinese stocks left few ripples in markets worldwide. The S&P 500 rose 0.7% to top the all-time high it had set last week. The Dow Jones Industrial Average climbed 431 points, or 1%, to hit its own record, while the Nasdaq comp... Read the Full Story |
|
From Our PartnersThis $1 stock has already made its mark with a listing on the prestigious NYSE. Now, it's sitting on prime land in one of America's richest gold districts, with the potential for a billion-dollar discovery. For savvy investors, this may be a $1 "Golden Ticket" to massive returns. | | | | Don't miss out on this rare opportunity. |
|
Markets | | |
The aerospace and defense industry has been a sustained beacon of strength in an otherwise volatile market. With geopolitical tensions escalating, including the ongoing Russia-Ukraine war and conflicts in the Middle East, the sector has steadily risen with momentum. Two giants in the industry, Loc... Read the Full Story |
|
Stocks | | | U.S. stocks edged back from their records Thursday after reports showed inflation was a touch warmer last month than expected and more workers filed for unemployment benefits last week. The S&P 500 slipped 0.2%, and the Dow Jones Industrial Average dipped 57 points, or 0.1%, after it likewise s... Read the Full Story |
|
From Our PartnersBiden and the democrats are rushing to roll out the new digital dollar system before the election in 2024
This could be your last chance to protect your cash from a central bank digital currency.
This new rule will give the government COMPLETE CONTROL over your money. | | | | Everything you need to know is clearly explained in this new guide>>>. |
|
Tech | | |
The medical device market, a powerhouse sector, is projected to exceed $600 billion by 2025. This growth is fueled by a combination of factors, including an aging population, rising healthcare costs, and rapid technological advancements powered by advanced artificial intelligence (AI) and biotechn... Read the Full Story |
|
Markets | | | China’s economic planning agency outlined details of measures aimed at boosting the economy on Tuesday but refrained from major spending initiatives. The piecemeal nature of the plans announced Tuesday appeared to disappoint investors who were hoping for bolder moves, and Shanghai's benchmark gave u... Read the Full Story |
|
Markets | | |
Though it hasn’t been without its ups and downs, Apple Inc’s (NASDAQ: AAPL) stock has effectively been trading sideways since July. In fact, the tech titan’s shares closed Tuesday’s session at the same price they were just one week before they popped to their last all-time ... Read the Full Story |
|
Markets | | | PepsiCo lowered its sales forecast for the year as consumers in the U.S., China and elsewhere continued to pull back on buying its snacks and drinks.The company, based in Purchase, New York, said Tuesday it now expects its organic revenue to increase in the low single-digit range for the year. It ha... Read the Full Story |
|
Markets | | | Germany's government said Wednesday that its economy, Europe's biggest, is on track to shrink for a second consecutive year — underlining the unpopular administration's troubles as it heads into a difficult election year.The new forecast that gross domestic product will shrink by 0.2% this year comp... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel. | | View Today's Stock Pick |
|
